首页|植入无导线起搏器的单中心临床观察

植入无导线起搏器的单中心临床观察

扫码查看
目的 报告单中心植入无导线起搏器的临床经验。方法 回顾性分析2020年1月至2023年5月于北京大学人民医院心内科行单腔无导线起搏器植入的所有患者数据。包括患者临床特点、植入原因及手术数据、并发症和随访结果。并根据患者年龄分为高龄组(≥80岁)和非高龄组(<80岁),进一步比较分析。结果 连续114例患者纳入研究,平均年龄(74。9±13。0)岁,男性61。4%。植入原因主要是高感染风险、缺少上腔静脉通路和高龄患者。经静脉导线拔除术后再植入比例高达63。2%。植入成功率为100%,术中高阈值发生率8。8%,围术期并发症4。4%。随访时间12(3,24)个月,随访期间患者的起搏参数保持稳定,慢性高阈值发生率3。5%,未发生起搏器感染、故障和起搏相关再住院事件。两组患者中高龄患者50例(43。8%),两组患者手术数据和随访结果均无统计学差异。结论 无导线起搏器是传统经静脉起搏器的一种安全有效的替代方法。
Clinical observation of leadless pacemaker implantation in a single center
Objective To report clinical experience of implanting leadless pacemaker in a single center.Methods The data of all patients with single chamber leadless pacemaker(LP)implantation in the Department of Cardiolo-gy of Peking University People's Hospital from January 2020 to May 2023 were retrospective reviewed,including clinical characteristics,reasons for implantation and operation data,complications and follow-up results.Results One hundred and fourteen consecutive patients[mean age(74.9±13.0)years old,70 males(61.4%)]were included in this study.The main reasons for implantation were high infection risk,lack of superior vena cava access and ad-vanced elderly patients.The reimplantation ratio after transvenous lead removal was as high as 63.2%.The implanta-tion success rate was 100%,the intraoperative high threshold incidence was 8.8%,and the perioperative complica-tions were 4.4%.During a follow-up period of 12(3,24)months,the pacing parameters remained stable,the chronic threshold incidence was 3.5%,and without pacemaker infection,malfunction and pacing-related rehospitalization.There were 50 elderly patients(43.8%),and there was no statistical difference in operation data and follow-up re-sults between the two groups.Conclusion Leadless pacemaker is a safe and effective alternative to traditional transvenous pacemakers.[Chinese Journal of Cardiac Pacing and Electrophysiology,2024,38(2):96-99]

CardiologyLeadless pacemakerTransvenous pacemakerComplicationsInfection

苑翠珍、昃峰、李鼎、段江波、何金山、吴寸草、周旭、杨丹丹、王龙、李学斌

展开 >

北京大学人民医院(北京 100044)

心血管病学 无导线起搏器 经静脉起搏器 并发症 感染

2024

中国心脏起搏与心电生理杂志
中国生物医学工程学会 武汉大学人民医院

中国心脏起搏与心电生理杂志

CSTPCD
影响因子:0.563
ISSN:1007-2659
年,卷(期):2024.38(2)
  • 12